For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Something beginning with M…medicines
Wednesday 28 March 2018, 06:00 AM
Graeme Jarvis, chief executive of Medicines New Zealand, goes in search of a place for medicines in the New Zealand Health Strategy
The priority is to use the investment to clear the backlog of recommended medicines sitting on the waiting list
Medicines or more specifically –
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.